IS8262A - Ferli til að stýra kristalbyggingu rísedrónats - Google Patents

Ferli til að stýra kristalbyggingu rísedrónats

Info

Publication number
IS8262A
IS8262A IS8262A IS8262A IS8262A IS 8262 A IS8262 A IS 8262A IS 8262 A IS8262 A IS 8262A IS 8262 A IS8262 A IS 8262A IS 8262 A IS8262 A IS 8262A
Authority
IS
Iceland
Prior art keywords
risedronate
crystal structure
controlling crystal
controlling
hydrate
Prior art date
Application number
IS8262A
Other languages
English (en)
Other versions
IS2915B (is
Inventor
Ellen Godlewski Jane
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of IS8262A publication Critical patent/IS8262A/is
Publication of IS2915B publication Critical patent/IS2915B/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Seasonings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Yarns And Mechanical Finishing Of Yarns Or Ropes (AREA)
  • Pens And Brushes (AREA)
IS8262A 2003-07-30 2006-01-25 Ferli til að stýra kristalbyggingu rísedrónats IS2915B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49122203P 2003-07-30 2003-07-30
PCT/US2004/022703 WO2005012314A1 (en) 2003-07-30 2004-07-15 Process for controlling crystal structure of risedronate

Publications (2)

Publication Number Publication Date
IS8262A true IS8262A (is) 2006-01-25
IS2915B IS2915B (is) 2014-12-15

Family

ID=34115482

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8262A IS2915B (is) 2003-07-30 2006-01-25 Ferli til að stýra kristalbyggingu rísedrónats

Country Status (20)

Country Link
US (1) US7002014B2 (is)
EP (1) EP1651656B1 (is)
JP (1) JP4423614B2 (is)
KR (1) KR100786044B1 (is)
CN (1) CN100439377C (is)
AT (1) ATE493423T1 (is)
AU (1) AU2004261561B9 (is)
BR (1) BRPI0413067A (is)
CA (1) CA2529470C (is)
CO (1) CO5660304A2 (is)
DE (1) DE602004030801D1 (is)
IL (1) IL172676A (is)
IS (1) IS2915B (is)
MA (1) MA27914A1 (is)
MX (1) MXPA06001129A (is)
NO (1) NO335393B1 (is)
NZ (1) NZ544030A (is)
RU (1) RU2319706C2 (is)
SG (1) SG144151A1 (is)
WO (1) WO2005012314A1 (is)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1775302A1 (en) 2005-10-11 2007-04-18 Sandoz A/S Method for preparing crystalline sodium risedronate
JP5052816B2 (ja) * 2006-04-26 2012-10-17 株式会社パーマケム・アジア 3−ピリジル−1−ヒドロキシエチリデン−1、1−ビスホスホン酸ナトリウム塩2.5水和物a型結晶の製造方法
JP5354858B2 (ja) * 2006-05-09 2013-11-27 株式会社Adeka スルホンアミド化合物の金属塩を含有するポリエステル樹脂組成物
JP2009536639A (ja) 2006-05-11 2009-10-15 アイエヌディー−スイフト ラボラトリーズ リミテッド 純リセドロン酸または塩を調製するための方法
WO2008044245A2 (en) * 2006-10-10 2008-04-17 Matrix Laboratories Ltd A process for the preparation of risedronate sodium hemipentahydrate
KR100828705B1 (ko) * 2006-12-04 2008-05-09 씨제이제일제당 (주) 리세드론산 나트륨 수화물의 제조방법
KR100775440B1 (ko) 2006-12-20 2007-11-12 동우신테크 주식회사 리세드로네이트 나트륨 헤미펜타히드레이트의 제조방법
KR100798855B1 (ko) * 2007-02-14 2008-01-28 주식회사 엔지켐 리세드론산 나트륨 헤미펜타하이드레이트의 제조방법
KR100812528B1 (ko) * 2007-04-12 2008-03-12 보령제약 주식회사 리세드로네이트 나트륨염의 헤미펜타히드레이트의 선택적결정화방법
WO2009050731A2 (en) * 2007-06-20 2009-04-23 Alkem Laboratories Ltd Novel process for preparing risedronic acid
WO2009034580A1 (en) * 2007-09-11 2009-03-19 Fleming Laboratories Limited Improved process for the preparation of risedronate sodium hemipentahydrate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3428524A1 (de) * 1984-08-02 1986-02-13 Boehringer Mannheim Gmbh, 6800 Mannheim Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
RU2120798C1 (ru) * 1991-11-22 1998-10-27 Проктер энд Гэмбл Фармасьютикалз, Инк. Твердая фармацевтическая композиция для перорального введения
PE20011061A1 (es) * 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato

Also Published As

Publication number Publication date
CN100439377C (zh) 2008-12-03
RU2006102357A (ru) 2006-07-27
MXPA06001129A (es) 2006-04-11
KR20060054297A (ko) 2006-05-22
AU2004261561A1 (en) 2005-02-10
JP4423614B2 (ja) 2010-03-03
NZ544030A (en) 2008-05-30
CA2529470C (en) 2010-11-23
ATE493423T1 (de) 2011-01-15
CO5660304A2 (es) 2006-07-31
EP1651656B1 (en) 2010-12-29
CN1823078A (zh) 2006-08-23
IS2915B (is) 2014-12-15
SG144151A1 (en) 2008-07-29
RU2319706C2 (ru) 2008-03-20
JP2007500189A (ja) 2007-01-11
WO2005012314A1 (en) 2005-02-10
IL172676A (en) 2010-12-30
US7002014B2 (en) 2006-02-21
NO20060950L (no) 2006-02-27
DE602004030801D1 (de) 2011-02-10
IL172676A0 (en) 2006-04-10
AU2004261561B9 (en) 2008-10-30
BRPI0413067A (pt) 2006-10-17
KR100786044B1 (ko) 2007-12-17
US20050026869A1 (en) 2005-02-03
EP1651656A1 (en) 2006-05-03
MA27914A1 (fr) 2006-05-02
CA2529470A1 (en) 2005-02-10
NO335393B1 (no) 2014-12-08
AU2004261561B2 (en) 2008-06-26

Similar Documents

Publication Publication Date Title
IS2915B (is) Ferli til að stýra kristalbyggingu rísedrónats
MY119968A (en) Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
EA200900779A1 (ru) Производные дигидропиридина, полезные как ингибиторы протеинкиназы
DK1539711T3 (da) Fremgangsmåde til fremstilling af calciumsaltet af rosuvastatin
EA200701358A1 (ru) Кристаллические формы гидрохлорида (r)-8-хлор-1-метил-2,3,4,5-тетрагидро-1h-3-бензазепина
IL172513A0 (en) Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
TW200740815A (en) P38 MAP kinase inhibitors and methods for using the same
NO20071619L (no) Fremgangsmate for fremstilling av indazol forbindelse
DK1592401T3 (da) Fremgangsmåde til ændring af medikamentkrystaldannelsen af mycophenolat-natriumsalt
ATE433988T1 (de) Phosphoramidatderivate
UA89057C2 (ru) Способы получения полиморфных форм мезотриона и применение регулирования рн
ATE435209T1 (de) Verfahren zur herstellung von montelukast-natrium
ATE497769T1 (de) Verfahren zur herstellung von ibandronat
DE602004005881D1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
DK1441724T3 (da) Fremgangsmåde til forögelse af endogene testosteronniveauer
DE60238056D1 (de) Verfahren zum kristallisieren von reduziertem coenzym q10 aus wässriger lösung
NO20060535L (no) Aztreonam-L-lysin og fremgangsmater for fremstilling av dette
NO20091806L (no) Framgangsmate for framstilling av bifosfonsyrer og salter av disse
MX2007007446A (es) Procesos para la produccion de 4-aminoquinazolinas.
FI20045307A0 (fi) Kipsilevyn pinnoite ja kipsilevy
ATE525073T1 (de) Verwendung von pyrimidylaminobenzamiden zur behandlung von durch modulation einer tie-2 kinase-aktivität verursachten krankheiten
EA200800200A1 (ru) Способ получения кристаллического периндоприла
NO20044629L (no) Fremgangsmate til fremstilling av sure salter av gemifloksasin.
NO20064410L (no) Fremgangsmate for fremstilling av tryptaseinhibitorer